Previous 10 | Next 10 |
home / stock / chexf / chexf news
OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, today announced that it will be requesting approval from the TSX Venture ...
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), announces a clarification to its press release issued Monday, November 19 th at 6:30 A.M. EST. The previous NR had stated that UNAHCO’s year-to-date purchase of OxC-beta™ Live...
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™ Livestock. This follows a 2 metric tonne order delivered to UNAHCO in Se...
OTTAWA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, strongly endorses the World Health Organization’s (WHO) initiative...
Avivagen ( OTCPK:CHEXF ) has entered into a distribution agreement for Vivamune Health Chews in the Vietnamese market with Viphavet Co. Ltd. More news on: Avivagen, Inc., Healthcare stocks news, Read more ...
OTTAWA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has entered into a distribution agreement for Vivamune™ Health Chews in the Vietnamese market with Viphavet Co. Ltd. This agreement reflects new interest in th...
OTTAWA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed its first distribution agreement for OxC-beta™ Livestock in Malaysia. With a total annual feed production of 4.4 million metric tonne...
OTTAWA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it has retained the services of Independent Trading Group (“ITG”) to conduct Market Making activities. ITG will trade shares of Avivagen on the TSX Venture E...
OTTAWA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that it has received its first order for OxC-beta™ Livestock in Thailand. The 100kg order also represents the first time OxC-beta™ Livestock will be use...
OTTAWA, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it will be attending BIOSPAIN 2018, in Seville, Spain, from September 25 th -27 th , 2018. Avivagen was invited to attend by the Department of Foreign Affairs, Trade & Dev...
News, Short Squeeze, Breakout and More Instantly...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...